CF patients are extremely vulnerable to a variety of pathogens, but it’s highly unusual to see a polyclonal infection involving 6 separate species.
Rapid Multiplex PCR Testing Detects Six Separate Pathogens in a Young Cystic Fibrosis Patient
Using Procalcitonin Measurements to Avoid Antibiotic Misuse in Patients with AECOPD
The Allegheny team asserts that this study demonstrates that adherence to a PCT guidance protocol is associated with decreased total antibiotic exposure without an increase in adverse outcomes.
“Take Off the Pump Handle”: BioFire CEO Randy Rasmussen on Meeting the New Challenges of Infectious Disease
By John Shultz Randy Rasmussen, CEO of BioFire Diagnostics, delivered the keynote speech at the 2018 bioMérieux “Night at the Museum” event held in Salt Lake City, Utah on July 9th, 2018. In his talk, Randy relates the challenges he has faced in his own career in the fight against infectious disease, while reflecting on …
The Necessity of Innovative Diagnostics in Controlling Antibiotic Resistance in Patients with Cystic Fibrosis
Dr. Hahn advocates for a more proactive microbiology lab to closely monitor the types of CF infections and to determine which antibiotics each infection is most susceptible. In the Children’s National study, researchers analyzed each sample in two different ways: standard lab culture and molecular testing.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...